@prefix epid: .
@prefix dc: .
@prefix geo: .
@prefix bibo: .
@prefix owl: .
@prefix void: .
@prefix event: .
@prefix skos: .
@prefix xsd: .
@prefix cc: .
@prefix ep: .
@prefix foaf: .
@prefix rdf: .
@prefix rdfs: .
@prefix eprel: .
@prefix dct: .
<>
rdfs:comment "The repository administrator has not yet configured an RDF license."^^xsd:string .
dc:format "text/html";
dc:title "HTML Summary of #24819 \n\nNovel psychoactive substances (NPS) : transnational project on different user groups, user characteristics, extent and patterns of use, market dynamics, and best practices in prevention.\n\n";
foaf:primaryTopic .
rdf:_1 ;
rdf:_2 ;
rdf:_3 ;
rdf:_4 ;
rdf:_5 ;
rdf:_6 ;
rdf:_7 ;
rdf:_8 ;
rdf:_9 .
bibo:authorList ;
dct:creator ,
,
,
,
,
,
,
,
;
dct:date "2015-10";
dct:isPartOf ;
dct:subject ,
,
,
,
,
,
;
dct:title "Novel psychoactive substances (NPS) : transnational project on different user groups, user characteristics, extent and patterns of use, market dynamics, and best practices in prevention."^^xsd:string;
rdf:type bibo:Article,
ep:EPrint,
ep:ResearchProjectEPrint;
rdfs:seeAlso .
rdf:type skos:Concept;
skos:prefLabel "Problem drugs and alcohol use"@en .
rdf:type skos:Concept;
skos:prefLabel "New (novel) psychoactive substances"@en .
rdf:type skos:Concept;
skos:prefLabel "Drugs and alcohol substance by legal status"@en .
rdf:type skos:Concept;
skos:prefLabel "Drugs and alcohol prevention"@en .
rdf:type skos:Concept;
skos:prefLabel "Illegal distribution of drugs (drug market / dealing)"@en .
rdf:type skos:Concept;
skos:prefLabel "Internet retailing (online sales)"@en .
rdf:type skos:Concept;
skos:prefLabel "Europe"@en .
foaf:familyName "Olssen"^^xsd:string;
foaf:givenName "B"^^xsd:string;
foaf:name "B Olssen"^^xsd:string;
rdf:type foaf:Person .
foaf:familyName "Van Hout"^^xsd:string;
foaf:givenName "Marie Claire"^^xsd:string;
foaf:name "Marie Claire Van Hout"^^xsd:string;
rdf:type foaf:Person .
foaf:familyName "Korf"^^xsd:string;
foaf:givenName "Dirk"^^xsd:string;
foaf:name "Dirk Korf"^^xsd:string;
rdf:type foaf:Person .
foaf:familyName "Nabbe"^^xsd:string;
foaf:givenName "T"^^xsd:string;
foaf:name "T Nabbe"^^xsd:string;
rdf:type foaf:Person .
foaf:familyName "Werse"^^xsd:string;
foaf:givenName "B"^^xsd:string;
foaf:name "B Werse"^^xsd:string;
rdf:type foaf:Person .
foaf:familyName "Wouters"^^xsd:string;
foaf:givenName "M"^^xsd:string;
foaf:name "M Wouters"^^xsd:string;
rdf:type foaf:Person .
foaf:familyName "Demetrovics"^^xsd:string;
foaf:givenName "Zsolt"^^xsd:string;
foaf:name "Zsolt Demetrovics"^^xsd:string;
rdf:type foaf:Person .
foaf:familyName "Bujalski"^^xsd:string;
foaf:givenName "M"^^xsd:string;
foaf:name "M Bujalski"^^xsd:string;
rdf:type foaf:Person .
foaf:familyName "Dabrowska"^^xsd:string;
foaf:givenName "K"^^xsd:string;
foaf:name "K Dabrowska"^^xsd:string;
rdf:type foaf:Person .
dc:format "text/html";
dc:title "HTML Summary of #24818 \n\nCASSANDRA (computer assisted solutions for studying the availability and distribution of novel psychoActive substances).\n\n";
foaf:primaryTopic .
rdf:_1 ;
rdf:_2 ;
rdf:_3 ;
rdf:_4 ;
rdf:_5 ;
rdf:_6 ;
rdf:_7 ;
rdf:_8 .
bibo:abstract "CASSANDRA seeks to create a multidisciplinary, cost effective approach to investigating the supply chain and diffusion of Novel Psychoactive Substances (NPS), by incorporating cutting edge technologies and new social trend indicators into the monitoring of NPS.\r\n\r\n\r\nCASSANDRA has been developed in partnership with the Institute of Psychiatry, King’s College London, United Kingdom, the Institute of Informatics and Telematics of the CNR, Pisa - Italy, and the Substance Abuse Research Centre, Waterford Institute of Technology (WIT), Ireland. \r\n\r\nThis partnership brings together expertise from different fields of research to develop a novel and innovative methodology to understand the supply chain and diffusion of NPS. This project will also capitalize on existing research and the strengths of the Psychonaut 2002, Psychonaut EWS, ReDNet, CODEMISUSED and ALICE RAP projects which for the past 10 years have investigated the role of the Internet in shaping drug use; On the work carried out at WIT which has shown how underground websites (Deep Web) are emerging as ideal market places for both illicit and licit substances, which are also set to revolutionise contemporary drug distribution and use, and are increasingly becoming very popular and more reliable and secure than negotiating illicit drug markets. It will also make use of the know-how developed in the past few years by the CNR as part of the CAPER, OpeNER, ASIA, and SoS projects which exploit open access information from several social media platforms and websites to find hidden connections among users, monitor social media for the detection and the analysis of events, and developed the technology needed to retrieve, store and analyse online data. \r\nTherefore, this project aims at using infodemiology, open source intelligence and qualitative methods to map the Internet to describe the supply chain and diffusion of the most used NPS. In particular we aim to: \r\n\r\n1) Map the availability and distribution chain of NPS across multiple websites and online environments (e.g. Tor, social media). \r\n2) Describe how the availability, promotion and distribution of NPS are evolving through out the duration of the project. \r\n3) Describe the life cycle stages of any given substance: Introduction, growth, maturity and/or decline. Including the displacement of established illegal drugs and/or other NPS."^^xsd:string;
bibo:authorList ;
dct:creator ,
,
,
,
,
,
,
;
dct:date "2015-02";
dct:isPartOf ;
dct:subject ,
,
;
dct:title "CASSANDRA (computer assisted solutions for studying the availability and distribution of novel psychoActive substances)."^^xsd:string;
rdf:type bibo:Article,
ep:EPrint,
ep:ResearchProjectEPrint;
rdfs:seeAlso .
rdf:type skos:Concept;
skos:prefLabel "New (novel) psychoactive substances"@en .
rdf:type skos:Concept;
skos:prefLabel "Internet retailing (online sales)"@en .
rdf:type skos:Concept;
skos:prefLabel "Europe"@en .
foaf:familyName "Davey"^^xsd:string;
foaf:givenName "Z"^^xsd:string;
foaf:name "Z Davey"^^xsd:string;
rdf:type foaf:Person .
foaf:familyName "Van Hout"^^xsd:string;
foaf:givenName "Marie Claire"^^xsd:string;
foaf:name "Marie Claire Van Hout"^^xsd:string;
rdf:type foaf:Person .
foaf:familyName "Drummond"^^xsd:string;
foaf:givenName "C"^^xsd:string;
foaf:name "C Drummond"^^xsd:string;
rdf:type foaf:Person .
foaf:familyName "Deluca"^^xsd:string;
foaf:givenName "Paolo"^^xsd:string;
foaf:name "Paolo Deluca"^^xsd:string;
rdf:type foaf:Person .
foaf:familyName "La Polla"^^xsd:string;
foaf:givenName "NM"^^xsd:string;
foaf:name "NM La Polla"^^xsd:string;
rdf:type foaf:Person .
foaf:familyName "Marchetti"^^xsd:string;
foaf:givenName "A"^^xsd:string;
foaf:name "A Marchetti"^^xsd:string;
rdf:type foaf:Person .
foaf:familyName "Bacciy"^^xsd:string;
foaf:givenName "C"^^xsd:string;
foaf:name "C Bacciy"^^xsd:string;
rdf:type foaf:Person .
foaf:familyName "Tesconi"^^xsd:string;
foaf:givenName "M"^^xsd:string;
foaf:name "M Tesconi"^^xsd:string;
rdf:type foaf:Person .
dc:format "text/html";
dc:title "HTML Summary of #25208 \n\nExamining the outcomes, variables, factors and experiences influencing recovery for participants in an abstinence-based residential intervention for drug and alcohol addiction.\n\n";
foaf:primaryTopic .
rdf:_1 .
bibo:authorList ;
dct:creator ;
dct:date "2015-01-15";
dct:isPartOf ;
dct:subject ,
,
,
,
,
,
,
,
,
,
,
;
dct:title "Examining the outcomes, variables, factors and experiences influencing recovery for participants in an abstinence-based residential intervention for drug and alcohol addiction."^^xsd:string;
rdf:type bibo:Article,
ep:EPrint,
ep:ResearchProjectEPrint;
rdfs:seeAlso .
rdf:type skos:Concept;
skos:prefLabel "Problem drugs and alcohol use"@en .
rdf:type skos:Concept;
skos:prefLabel "Drugs and alcohol abstinence" .
rdf:type skos:Concept;
skos:prefLabel "Drugs and alcohol recovery"@en .
rdf:type skos:Concept;
skos:prefLabel "Physical health" .
rdf:type skos:Concept;
skos:prefLabel "Mental health" .
rdf:type skos:Concept;
skos:prefLabel "HJ Treatment method"@en .
rdf:type skos:Concept;
skos:prefLabel "Residential facility"@en .
rdf:type skos:Concept;
skos:prefLabel "Social psychology"@en .
rdf:type skos:Concept;
skos:prefLabel "Quality of life"@en .
rdf:type skos:Concept;
skos:prefLabel "Sociology and anthropology"@en .
rdf:type skos:Concept;
skos:prefLabel "Policy on drugs and alcohol"@en .
rdf:type skos:Concept;
skos:prefLabel "Ireland"@en .
foaf:familyName "Dwyer"^^xsd:string;
foaf:givenName "David"^^xsd:string;
foaf:name "David Dwyer"^^xsd:string;
rdf:type foaf:Person .
dc:format "text/html";
dc:title "HTML Summary of #24929 \n\nMeasuring and modelling the extent of addiction treatment and associated outcomes among ageing opiate users using routine health surveillance data.\n\n";
foaf:primaryTopic .
rdf:_1 ;
rdf:_2 .
bibo:authorList ;
dct:creator ,
;
dct:date "2014-09-01";
dct:isPartOf ;
dct:subject ,
,
,
;
dct:title "Measuring and modelling the extent of addiction treatment and associated outcomes among ageing opiate users using routine health surveillance data."^^xsd:string;
rdf:type bibo:Article,
ep:EPrint,
ep:ResearchProjectEPrint;
rdfs:seeAlso .
rdf:type skos:Concept;
skos:prefLabel "Opioids (opiates)"@en .
rdf:type skos:Concept;
skos:prefLabel "Elderly / Older person" .
rdf:type skos:Concept;
skos:prefLabel "Intravenous / injecting drug user"@en .
rdf:type skos:Concept;
skos:prefLabel "Drug user"@en .
foaf:familyName "Carew"^^xsd:string;
foaf:givenName "Anne Marie"^^xsd:string;
foaf:name "Anne Marie Carew"^^xsd:string;
rdf:type foaf:Person .
foaf:familyName "Comiskey"^^xsd:string;
foaf:givenName "Catherine"^^xsd:string;
foaf:name "Catherine Comiskey"^^xsd:string;
rdf:type foaf:Person .
dc:format "text/html";
dc:title "HTML Summary of #21519 \n\nImage and performance / steroids enhancing drugs (IPEDs).\n\n";
foaf:primaryTopic .
rdf:_1 ;
rdf:_2 .
bibo:abstract "There are potential health risks associated with the use of Image and Performance Enhancing drugs but no research has reliably shown what adverse side-effects people actually experience. There is currently no reliable way of estimating how many people use these drugs. This makes providing services and advice for this group extremely difficult. It is hoped that this survey will help us to better understand patterns of use and what side-effects people experience and how they are treated. The research programme is designed to better understand the longer term implications of use and to highlight emerging trends in the nature of use."^^xsd:string;
bibo:authorList ;
dct:creator ,
;
dct:date "2014-02-12";
dct:isPartOf ;
dct:subject ,
,
;
dct:title "Image and performance / steroids enhancing drugs (IPEDs)."^^xsd:string;
rdf:type bibo:Article,
ep:EPrint,
ep:ResearchProjectEPrint;
rdfs:seeAlso .
rdf:type skos:Concept;
skos:prefLabel "Steroids of abuse"@en .
rdf:type skos:Concept;
skos:prefLabel "Research and evaluation"@en .
rdf:type skos:Concept;
skos:prefLabel "Ireland"@en .
foaf:familyName "Bingham"^^xsd:string;
foaf:givenName "Tim"^^xsd:string;
foaf:name "Tim Bingham"^^xsd:string;
rdf:type foaf:Person .
foaf:familyName "Van Hout"^^xsd:string;
foaf:givenName "Marie Claire"^^xsd:string;
foaf:name "Marie Claire Van Hout"^^xsd:string;
rdf:type foaf:Person .
rdfs:label "PRESS_RELEASE_2013__Over_the_Counter_Codeine_Use_Misuse_and_Dependence.docx"^^xsd:string .
rdfs:label "indexcodes.txt"^^xsd:string .
dc:format "text/html";
dc:title "HTML Summary of #20561 \n\nOver the Counter Codeine Use Misuse and Dependence (CODEMISUSED).\n\n";
foaf:primaryTopic .
dct:hasPart ;
ep:hasFile ;
rdf:type bibo:Document,
ep:Document;
rdfs:label "Over the Counter Codeine Use Misuse and Dependence (CODEMISUSED). (Microsoft Word)"^^xsd:string .
dct:hasPart ;
ep:hasFile ;
eprel:isIndexCodesVersionOf ;
eprel:isVersionOf ;
eprel:isVolatileVersionOf ;
rdf:type ep:Document;
rdfs:label "Over the Counter Codeine Use Misuse and Dependence (CODEMISUSED). (Other)"^^xsd:string .
rdf:_1 ;
rdf:_2 ;
rdf:_3 ;
rdf:_4 ;
rdf:_5 .
bibo:abstract "Contemporary research has underscored the need for ‘increased pharmaco- vigilance’ around codeine dispensing as the most commonly consumed opiate worldwide. Codeine represents an interesting quandary in terms of its regulated status, with individuals varying in their metabolism of codeine, estimation of safe dosages, and potential for misuse and dependence. Although effects are milder than heroin, potential for habit forming use, misuse and addiction remains of concern, with physical dependence occurring with regular use over a short period of time. Within trajectories of codeine use, misuse and dependence, a variety of distinct sub groups exist in the form of pain patients, elderly, youth, parents, recreational, problematic and opiate dependent drug users, and each with their own motives, patterns and outcomes for use. Increases in addiction treatment uptakes and reporting of adverse health consequences relating to additives in combination analgesics containing codeine and ibuprofen/paracetamol are observed globally. \r\n\r\nThe CODEMISUSED collaboration are investigating this public health issue in order to present data on prescribed and over the counter (OTC) codeine use, misuse and dependence in partner countries and from a variety of perspectives (codeine patients, prescribers, pharmacists, addiction treatment specialists, drug users, customers and addiction treatment patients) so as to inform the design of patient information, professional competency training and education, primary care and pharmacy risk detection, surveillance and monitoring, referral, treatment and detoxification initiatives for innovative use in the pharmaceutical, pharmacy medical and treatment professions.\r\n\r\nIndustry (pharmacy chains) and academia exchanges in the form of secondments of staff, workshops, seminars and conferences have occurred throughout the duration of CODEMISUSED to date, and have been paramount to the informed success of work package design, implementation of research by virtue of the collaboration, exchange knowledge and expertise from academics and pharmacy staff. 85% of the inter-sectorial secondment months have been completed. All Marie Curie Fellows are involved in outreach when on secondment which involves dissemination within the host organisation, and home organisation on return from secondments, and also engaging with local services and key stakeholders whilst on secondment and whilst working on the scientific objectives of CODEMISUSED"^^xsd:string;
bibo:authorList ;
dc:hasVersion ;
dct:creator ,
,
,
,
;
dct:date "2013-09-01";
dct:isPartOf ;
dct:subject ,
,
,
,
,
,
;
dct:title "Over the Counter Codeine Use Misuse and Dependence (CODEMISUSED)."^^xsd:string;
ep:hasDocument ,
;
ep:hasPublished ;
rdf:type bibo:Article,
ep:EPrint,
ep:ResearchProjectEPrint;
rdfs:seeAlso .
rdf:type skos:Concept;
skos:prefLabel "Drugs and alcohol effects and consequences"@en .
rdf:type skos:Concept;
skos:prefLabel "Codeine"@en .
rdf:type skos:Concept;
skos:prefLabel "Over the counter drug (medicine / medication)"@en .
rdf:type skos:Concept;
skos:prefLabel "Internet retailing (online sales)"@en .
rdf:type skos:Concept;
skos:prefLabel "Ireland"@en .
rdf:type skos:Concept;
skos:prefLabel "United Kingdom"@en .
rdf:type skos:Concept;
skos:prefLabel "South Africa" .
foaf:familyName "Gooney"^^xsd:string;
foaf:givenName "Martina"^^xsd:string;
foaf:name "Martina Gooney"^^xsd:string;
rdf:type foaf:Person .
foaf:familyName "Van Hout"^^xsd:string;
foaf:givenName "Marie Claire"^^xsd:string;
foaf:name "Marie Claire Van Hout"^^xsd:string;
rdf:type foaf:Person .
foaf:familyName "Foley"^^xsd:string;
foaf:givenName "Michelle"^^xsd:string;
foaf:name "Michelle Foley"^^xsd:string;
rdf:type foaf:Person .
foaf:familyName "Bergin"^^xsd:string;
foaf:givenName "Michael"^^xsd:string;
foaf:name "Michael Bergin"^^xsd:string;
rdf:type foaf:Person .
foaf:familyName "Wells"^^xsd:string;
foaf:givenName "John"^^xsd:string;
foaf:name "John Wells"^^xsd:string;
rdf:type foaf:Person .
dc:format "text/html";
dc:title "HTML Summary of #20264 \n\nLongitudinal monitoring and process evaluation of methadone maintenance clients experiences of community and residential detox in Dublin over a period of 24 months.\n\n";
foaf:primaryTopic .
rdf:_1 .
bibo:authorList ;
dct:creator ;
dct:date "2013-06";
dct:isPartOf ;
dct:subject ,
,
,
,
;
dct:title "Longitudinal monitoring and process evaluation of methadone maintenance clients experiences of community and residential detox in Dublin over a period of 24 months."^^xsd:string;
rdf:type bibo:Article,
ep:EPrint,
ep:ResearchProjectEPrint;
rdfs:seeAlso .
rdf:type skos:Concept;
skos:prefLabel "Methadone maintenance"@en .
rdf:type skos:Concept;
skos:prefLabel "Patient attitude toward treatment"@en .
rdf:type skos:Concept;
skos:prefLabel "Community-based treatment (primary care)"@en .
rdf:type skos:Concept;
skos:prefLabel "Residential facility"@en .
rdf:type skos:Concept;
skos:prefLabel "Dublin"@en .
foaf:familyName "Van Hout"^^xsd:string;
foaf:givenName "Marie Claire"^^xsd:string;
foaf:name "Marie Claire Van Hout"^^xsd:string;
rdf:type foaf:Person .
dc:format "text/html";
dc:title "HTML Summary of #11888 \n\nNational Drug-Related Deaths Index (NDRDI)\n\n";
foaf:primaryTopic .
rdf:_1 ;
rdf:_2 .
bibo:abstract "To ensure complete (90%) and accurate (95%) reporting for drug and alcohol-related deaths among substance users in order to inform policy and practice in the harm reduction and prevention areas. The purposes of having such data are manifold:\r\n\r\n- Accurate information on drug and alcohol-related deaths and deaths among substance users would enable us to make a judgement on whether broad policy objectives are being met or not.\r\n\r\n- It would inform Local Drugs Task Forces and Regional Drugs Task Forces on specific prevention, treatment and rehabilitation issues that would be of relevance at community level.\r\n- It would inform decision-making in terms of putting preventive measures in place to reduce premature drug and alcohol-related mortality.\r\n\r\n- It would enable us to determine the balance of harm to public health by drug type."^^xsd:string;
bibo:authorList ;
dct:creator ,
;
dct:date "2005-09";
dct:isPartOf ;
dct:subject ,
,
;
dct:title "National Drug-Related Deaths Index (NDRDI)"^^xsd:string;
rdf:type bibo:Article,
ep:EPrint,
ep:ResearchProjectEPrint;
rdfs:seeAlso .
rdf:type skos:Concept;
skos:prefLabel "Drugs and alcohol related mortality / death"@en .
rdf:type skos:Concept;
skos:prefLabel "Epidemiology"@en .
rdf:type skos:Concept;
skos:prefLabel "Ireland"@en .
foaf:familyName "Lyons"^^xsd:string;
foaf:givenName "Suzi"^^xsd:string;
foaf:name "Suzi Lyons"^^xsd:string;
rdf:type foaf:Person .
foaf:familyName "Lynn"^^xsd:string;
foaf:givenName "Ena"^^xsd:string;
foaf:name "Ena Lynn"^^xsd:string;
rdf:type foaf:Person .
dc:format "text/html";
dc:title "HTML Summary of #11899 \n\nNational Registry of Deliberate Self Harm.\n\n";
foaf:primaryTopic .
rdf:_1 ;
rdf:_2 ;
rdf:_3 ;
rdf:_4 .
bibo:abstract "To establish the extent of the problem of deliberate self harm presentations to hospital accident and emergency departments in Ireland. To detail the nature of the self-harming behaviour involved. To identify the groups and areas with the highest rates of deliberate self harm."^^xsd:string;
bibo:authorList ;
dct:creator ,
,
,